A faster drug approval route spurs rare kidney disease research; monkeypox vaccine dosing plan hits hurdles

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Faster drug approval route sparks investment in rare kidney disease treatments By Isabella Cueto Adobe Drug companies, regulators, and researchers are collaborating to develop new treatments for rare kidney diseases. Read More U.S. plan to stretch monkeypox vaccine supply already hitting hurdles By Helen Branswell and Theresa Gaffney PATRICK T. FALLON/AFP via Getty Images Some local health officials are reporting that only three or four doses of monkeypox vaccine can be extracted from a vial, rather than five. Read More Scientists are racing to develop home tests that measure protection against Covid-19 By Edward Chen PATRICK T. FALLON/ Getty Scientists are trying to develop home tests that can tell people whether they have neutralizing antibodies that protect against SARS-CoV-2. Read More Sponsor content by STAT+ ESMO in 30 Seconds Stay on top of the most impactful developments coming out of the European Society of Medical Oncology conference by signing up for our free pop-up newsletter, ESMO in 30 Seconds. You'll receive the best coverage of the convention right to your inbox, Sept. 9 – 11.  Sign up now. Opinion: STAT+: How machine learning and automation can solve biomanufacturing scale-up challenges By Preston Toole Adobe New biomanufacturing approaches are needed to help solve biotechnology's age-old commercial hurdle: how to scale up manufacturing. Read More Tuesday, August 23, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser